Omega Healthcare Investors, Inc. (OHI) Market Cap

Omega Healthcare Investors, Inc. (OHI) has a market capitalization of $14.27B, based on the latest available market data.

Financials updated after earnings reported 2025-12-31.

Sector: Real Estate
Industry: REIT - Healthcare Facilities
Employees: 60
Exchange: New York Stock Exchange
Headquarters: Hunt Valley, MD, US
Website: https://www.omegahealthcare.com

Loading company profile...

Expand full investment commentary ▼

📘 OMEGA HEALTHCARE INVESTORS REIT IN (OHI) — Investment Overview

🧩 Business Model Overview

Omega Healthcare Investors, Inc. (OHI) operates as a real estate investment trust (REIT) specializing in investments within the long-term healthcare industry, primarily skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs). The company owns a geographically diversified portfolio of healthcare properties, which it leases to a wide variety of operator tenants using triple-net lease agreements. Under this structure, tenants bear responsibility for property-level expenses such as maintenance, insurance, and taxes, offering Omega predictable income and reducing operational risk. Omega partners with both national and regional operators, placing a strong focus on properties in the U.S. and select international markets such as the United Kingdom.

💰 Revenue Streams & Monetisation Model

Omega’s primary revenue source is rental income derived from leasing its properties under long-term, triple-net leases. In these contracts, tenants pay a fixed rent, which can include scheduled escalators linked to inflation or pre-agreed rates, ensuring rental growth over time. Additional income may be generated from mortgage loans and other real estate financing arrangements, where Omega provides capital to operators in exchange for interest income, often secured by healthcare real estate assets. These predictable and contractually obligated rental and interest streams form the backbone of Omega’s monetization model, supporting its ability to pay regular dividends to shareholders.

🧠 Competitive Advantages & Market Positioning

Omega benefits from several enduring competitive advantages. The company’s scale and experience in the skilled nursing sector allows it to deploy capital efficiently, source attractive deals, and maintain robust tenant relationships. Its diversified portfolio reduces exposure to single tenants, operators, or regional downturns, and its emphasis on triple-net leases shifts operational and expense risks to tenants. Long-term leases help smooth out near-term industry volatility and facilitate consistent cash flows. Omega’s established reputation as a reliable capital partner also helps it secure favorable deals with leading healthcare operators, providing attractive risk-adjusted returns while offering tenants stability and support for growth initiatives. Regulatory expertise in navigating healthcare reimbursement dynamics and facility licensure requirements further strengthen Omega’s market position.

🚀 Multi-Year Growth Drivers

Several secular and structural tailwinds underpin Omega’s long-term growth: - **Aging Demographics:** Demand for skilled nursing and long-term care facilities is poised to rise, driven by the aging of the Baby Boomer generation and increased prevalence of chronic conditions requiring facility-based care. - **Industry Consolidation:** Financial constraints on smaller operators, regulatory complexity, and economies of scale promote industry consolidation, creating opportunities for Omega to partner with stronger, better-capitalized tenants and selectively acquire attractive assets. - **Value-Based Care Trends:** Shifts in healthcare reimbursement—including the migration towards value-based payment models—drive SNF and ALF operators to seek capital partners who bring operational flexibility and long-term investment horizons. - **Selective New Development and Redevelopment:** Omega’s experience managing facility upgrades and new developments enables it to add value to its portfolio, meet evolving regulatory and care standards, and capture higher returns through strategic investments. - **Balance Sheet Strength:** Prudent capital management, including maintaining access to unsecured debt markets and favorable borrowing costs, facilitates ongoing investment without over-extending the company’s risk profile.

⚠ Risk Factors to Monitor

Investment in Omega entails exposure to several material risks: - **Regulatory & Reimbursement Risk:** The financial viability of SNF tenants is highly dependent on Medicare and Medicaid reimbursement rates and regulatory requirements. Adverse policy changes, budget cuts, or increased scrutiny can strain tenant cash flows and, by extension, Omega’s rental streams. - **Tenant Credit Risk:** Concentration with key operators or geographic markets may expose Omega to defaults if a major tenant faces financial stress. - **Occupancy and Demand Cyclicality:** Although demographic trends are favorable, short-term fluctuations in occupancy, shifts in patient acuity, or changes in post-acute care trends can impact tenant profitability. - **Interest Rate Sensitivity:** As a yield-oriented REIT, Omega’s valuation and cost of capital are sensitive to interest rate movements. Rising rates may increase debt costs and reduce the relative attractiveness of dividend yields. - **Asset Liquidity and Obsolescence:** Specialized healthcare real estate can be illiquid, and properties may require significant capital expenditures to remain compliant with regulatory and patient care standards.

📊 Valuation & Market View

Omega is typically valued using a combination of price-to-funds from operations (P/FFO), net asset value (NAV) premiums or discounts, and its dividend yield relative to peers in the healthcare REIT sector. Its valuation reflects market expectations for rent sustainability, tenant health, portfolio quality, and dividend safety. Investors generally weigh Omega’s relatively high yield and secure rental streams against risks associated with tenant concentration, regulatory uncertainties, and cyclicality inherent in the healthcare services domain. Its valuation often commands a premium or discount depending on prevailing sentiment regarding sector reimbursement risk and management’s capital allocation record. Coverage ratios, balance sheet leverage, and the ability to fund future growth remain key metrics for market participants.

🔍 Investment Takeaway

Omega Healthcare Investors offers investors targeted exposure to the essential healthcare infrastructure underlying skilled nursing and assisted living facilities. Its business model provides stable, long-term rental income with contractual inflation protection, backed by a history of prudent capital management and shareholder-aligned dividend policies. The company is positioned to benefit from secular demographic trends, ongoing industry consolidation, and the expertise required to manage complex healthcare real estate. However, the investment case must be balanced against the inherent risks of regulatory change, tenant health, and the sensitivity to both interest rates and sector-specific cyclicality. For income-oriented investors seeking stable yield backed by fundamental demographic and real estate trends, Omega represents a well-managed—albeit specialized—REIT worth considering for diversified portfolios.

⚠ AI-generated — informational only. Validate using filings before investing.

📢 Show latest earnings summary

OHI Q4 2025 Earnings Summary

Overall summary: OHI delivered a strong Q4 with double-digit revenue growth, higher AFFO/FAD, and meaningful deleveraging. Management accelerated capital deployment ($1.1B in 2025), expanded its Sabra partnership, launched RIDEA investments, and entered Canada with a secured development loan, all while strengthening liquidity and pushing maturities to 2027. 2026 AFFO guidance of $3.15–$3.25/sh reflects confidence in a robust pipeline and improving operator coverage, with supportive regulatory developments. Genesis remains a watched item but is performing under lease and is expected to repay OHI’s loans upon sale completion; overall tone and outlook are positive.

Growth

  • Q4 revenue rose to $319M from $279M (+~14% YoY)
  • Full-year 2025 AFFO and FAD both grew >8% YoY
  • Core portfolio TTM EBITDAR coverage improved to 1.57x (from 1.55x in Q2 2025)
  • Q/Q FAD per share increased by $0.01 to $0.76
  • $1.1B capital deployed in 2025 fueled EBITDA and revenue growth

Business development

  • Closed two RIDEA transactions totaling ~$80M in Q4
  • Acquired 4 U.S. senior housing assets for $37M (RIDEA) and 49% of a Class A CCRC in NC for $43M (RIDEA)
  • Expanded Sabra relationship: $222M real estate JV (49% interest in 64 facilities) and, on Jan 1, 9.9% equity in Sabra operating company for $93M (minimum 8% cash return; excess accrues)
  • Purchased 13 SNFs in GA for $109M (10.6% lease yield) and a senior housing asset in AL for $10.3M (RIDEA)
  • Bought a U.K. care home for $16M; funded $16M of real estate loans at 10% with upside options
  • Committed up to $64M to develop 5 replacement LTC facilities in Ontario, Canada (10% current-pay loan, convertible to 34.9% equity; collateral is a 21-facility portfolio valued >$130M)
  • Post-quarter additional investments closed: $212M
  • Genesis exposure: leases 31 facilities ($52M annual rent); OHI holds $129M first-lien term loan and provided $8M of a $30M DIP; Genesis continues to pay full rent

Financials

  • Q4 net income: $172M ($0.55/sh) vs $116M ($0.41/sh) YoY
  • Q4 AFFO: $250M ($0.80/sh); FAD: $238M ($0.76/sh)
  • Dividend payout ratio: 84% of AFFO and 88% of FAD
  • Q/Q FAD drivers: contribution from $485M of recent investments; Maplewood paid $18.9M (+$0.2M vs Q3); ~$1M lower net interest expense; partially offset by ~$2.1M FAD reduction from asset sales and dilution from 7.8M shares/OP units issued over last two quarters
  • Portfolio size: 1,111 facilities (62% SNF/transitional care; 38% U.S. senior housing & U.K. care homes)
  • 2026 adjusted FFO guidance: $3.15–$3.25/sh, assuming $15–$25M per quarter of asset sales and significant loan repayments

Capital & funding

  • Reduced funded debt by >$700M in Q4: repaid $600M senior notes, GBP 183M secured mortgage, and $428.5M term loan early
  • Financed with cash, revolver, and draw on $300M delayed-draw term loan
  • Issued 5.5M OP units (~$222M) to fund Q4 investments; established new $2B ATM program
  • Liquidity at 12/31/25: $27M cash and >$1.7B available on $2B revolver
  • Fixed charge coverage: 5.8x; leverage reduced to 3.51x
  • Next debt maturity: April 2027

Operations & strategy

  • Active portfolio management improving tenant credit; no material open operator issues besides Genesis
  • Focus on risk-adjusted FAD/share growth; target unlevered IRR in low–mid teens (no cap-rate compression assumed)
  • Broadened structures to include RIDEA, JVs, and varied lease formats across U.S. SNF, U.S. senior housing, and U.K. care homes
  • Expect Sabra to be largest revenue source by year-end 2026
  • Aim to achieve strongest tenant credit profile and balance sheet in company history by year-end 2026

Market & outlook

  • 2026 pipeline remains strong with substantial U.S. and U.K. opportunities, including off-market via operator relationships
  • Industry fundamentals and operator coverage trends remain favorable
  • Regulatory updates supportive: 4% Medicare cut averted; federal minimum staffing rule repealed via interim final rule
  • CMS 2027 Medicare Advantage proposal (flat rates) expected to have minimal portfolio impact due to low MA penetration and solid coverage
  • Guidance excludes unannounced investments or additional capital markets actions beyond stated assumptions

Risks & headwinds

  • Genesis Chapter 11: sale to 101 West State Street approved; financing and closing pending; unsecured creditors committee challenging collateral values; resolution expected Q3–Q4 2026
  • Timing risk around assumed loan repayments and asset sales embedded in 2026 guidance
  • Potential reimbursement pressures from state responses to OBBBA and Medicare Advantage dynamics
  • Execution risk on RIDEA platform, JV structures, and international expansion
  • Equity/OP unit issuance dilution and asset sale headwinds

Sentiment: positive

📊 Omega Healthcare Investors, Inc. (OHI) — AI Scoring Summary

📊 AI Stock Rating — Summary

Omega Healthcare Investors, Inc. (OHI) reported a revenue of $319.2 million for the quarter ended December 31, 2025, with a net income of $172 million, resulting in an EPS of $0.58. Despite healthy net margins, free cash flow data and operating cash flows were unavailable, making FCF evaluation less clear. Year-over-year revenue growth appears stable, supported by consistent quarterly dividends of $0.67 per share, reflecting shareholder commitment. The company's total assets reached $9.63 billion against total liabilities of $4.61 billion, with equity standing at $5.44 billion, and net debt marginally at -$27 million, signifying a strong balance sheet. No activities in capital expenditures or buybacks were reported. Analysts see a consensus price target at $49, which provides a balanced outlook in line with current trends. Omega's stable dividends and prudent debt management are notable, yet without free cash flow and detailed operating cash flows, complete assessment of cash flow robustness is hindered. Overall, financial stability is bolstered by strong net income and asset quality, although growth prospects might depend on expanding revenue sources or operational enhancements.

AI Score Breakdown

Revenue Growth — Score: 7/10

Revenue growth is stable with $319.2 million, driven by consistent operations in the healthcare investment sector.

Profitability — Score: 8/10

High net margins and EPS of $0.58 reflect strong profitability and operational efficiency.

Cash Flow Quality — Score: 5/10

Absence of operating cash flow and FCF data limits the ability to assess cash flow quality, though dividends suggest cash stability.

Leverage & Balance Sheet — Score: 9/10

Strong balance sheet with $9.63 billion in assets and low net debt of -$27 million highlights financial resilience.

Shareholder Returns — Score: 8/10

Consistent quarterly dividends of $0.67 underline strong shareholder returns, although buybacks are absent.

Analyst Sentiment & Valuation — Score: 6/10

Consensus target price aligns with current trends, providing a balanced valuation outlook among analysts.

⚠ AI-generated — informational only, not financial advice.

SEC Filings

Related Companies in Real Estate

REG logo

REGENCY CENTERS REIT CORP (REG)

Real Estate

$14.45B

LAMR logo

LAMAR ADVERTISING COMPANY CLAS (LAMR)

Real Estate

$13.99B

GLPI logo

GAMING AND LEISURE PROPERTIES REIT (GLPI)

Real Estate

$13.84B

JLL logo

JONES LANG LASALLE INC (JLL)

Real Estate

$14.95B

HST logo

HOST HOTELS & RESORTS REIT INC (HST)

Real Estate

$13.47B

ELS logo

EQUITY LIFESTYLE PROPERTIES REIT I (ELS)

Real Estate

$13.02B